 |
Doug Macron is the editor of GenomeWeb's Gene Silencing News. He covers research and therapeutic applications of RNAi, miRNA, and other gene-silencing technologies. E-mail Doug Macron or follow his GenomeWeb Twitter account at @Genesilencing. |
Dicerna Releases Data from Liver Cancer Program as Prostate Cancer Effort Advances
September 20, 2012
Dicerna Releases Data from Liver Cancer Program as Prostate Cancer Effort Advances
Full-text access for premium subscribers only.
Existing premium subscribers login here.
New to GenomeWeb? Register here quickly.
New to GenomeWeb? Register here quickly.
Related Stories
- Tekmira on Track to Move Cancer Drug into Phase II, Name New Clinical Candidate in ‘13
May 16, 2013 / Gene Silencing News - Alnylam Publishes Phase I Data on Liver Cancer Drug
January 31, 2013 / Gene Silencing News - Alnylam Adds New Program to Pipeline as It Shelves Anemia Candidate
January 10, 2013 / Gene Silencing News - Alnylam Licenses Chinese Rights to Liver Cancer Drug
July 12, 2012 / Gene Silencing News - Alnylam Data Shows 'Majority' of Patients in Liver Cancer Extension Study Have Stable Disease
June 7, 2012 / Gene Silencing News